Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
2
×
national blog main
abaloparatide
amgen
andrew berens
avapritinib
biotech
blueprint medicines
boston
boston blog main
cancer
deciphera pharmaceuticals
europe blog main
europe top stories
european commission
fda
gastrointestinal stromal tumor
gist
gleevec
imatinib
national
osteoporosis
radius health
regorafenib
ripretinib
romosozumab
san francisco blog main
san francisco top stories
steve hoerter
stivarga
sunitinib
sutent
svb leerink
teriparatide
ucb
What
approval
2
×
drug
2
×
medicine
2
×
amgen
amgen’s
announced
blueprint
cancer
carries
chasing
deadly
deciphera
developed
europe
european
fda
filing
forms
gi
heart
marketing
morning
nod
osteoporosis
pharamceuticals
plans
raise
risk
seek
treats
tumor
type
warning
wins
Language
unset
2
×
Current search:
medicine
×
drug
×
approval
×
" life sciences "
×
unset
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug